Cargando…

Human Norovirus: Experimental Models of Infection

Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Todd, Kyle V., Tripp, Ralph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410082/
https://www.ncbi.nlm.nih.gov/pubmed/30759780
http://dx.doi.org/10.3390/v11020151
_version_ 1783402152597651456
author Todd, Kyle V.
Tripp, Ralph A.
author_facet Todd, Kyle V.
Tripp, Ralph A.
author_sort Todd, Kyle V.
collection PubMed
description Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo infection models has limited the development of HuNoV countermeasures. Experimental infection of human volunteers and the use of related viruses such as murine NoV have provided helpful insights into HuNoV biology and vaccine and therapeutic development. There remains a need for robust animal models and reverse genetic systems to further HuNoV research. This review summarizes available HuNoV animal models and reverse genetic systems, while providing insight into their usefulness for vaccine and therapeutic development.
format Online
Article
Text
id pubmed-6410082
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64100822019-04-01 Human Norovirus: Experimental Models of Infection Todd, Kyle V. Tripp, Ralph A. Viruses Review Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo infection models has limited the development of HuNoV countermeasures. Experimental infection of human volunteers and the use of related viruses such as murine NoV have provided helpful insights into HuNoV biology and vaccine and therapeutic development. There remains a need for robust animal models and reverse genetic systems to further HuNoV research. This review summarizes available HuNoV animal models and reverse genetic systems, while providing insight into their usefulness for vaccine and therapeutic development. MDPI 2019-02-12 /pmc/articles/PMC6410082/ /pubmed/30759780 http://dx.doi.org/10.3390/v11020151 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Todd, Kyle V.
Tripp, Ralph A.
Human Norovirus: Experimental Models of Infection
title Human Norovirus: Experimental Models of Infection
title_full Human Norovirus: Experimental Models of Infection
title_fullStr Human Norovirus: Experimental Models of Infection
title_full_unstemmed Human Norovirus: Experimental Models of Infection
title_short Human Norovirus: Experimental Models of Infection
title_sort human norovirus: experimental models of infection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410082/
https://www.ncbi.nlm.nih.gov/pubmed/30759780
http://dx.doi.org/10.3390/v11020151
work_keys_str_mv AT toddkylev humannorovirusexperimentalmodelsofinfection
AT trippralpha humannorovirusexperimentalmodelsofinfection